MXCT
MAXCYTE, INC.
Next earnings Aug 10, 2026 · consensus $-0.10 EPS, $6.76M rev
Last earnings +0.6% on 2026-05-12
$1.19
▲ +1.28%$1.19▼ -43.60%
over 1Y
L $0.68EODHDH $2.33
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+1.3%
1W+5.3%
1M+19.0%
3M+72.6%
YTD-23.2%
1Y-43.6%
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 13 analysts
Buy
Conservative balance sheet (liabilities/equity 0.18x); but revenue declined -5.7% YoY.
MAXCYTE, INC. shows $21.0M in FY2025 revenue (-5.7% YoY), a -213.0% net margin, and -26.0% ROE.
Sources: SEC EDGAR (CIK 0001287098, latest 10-Q filed 2026-05-13) · EODHD · as of 6/25/2026, 11:36:30 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.